APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bromhexine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bromhexine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchBromhexine Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Bromhexine Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Bromhexine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bromhexine Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Bromhexine Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Bromhexine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bromhexine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bromhexine include Abbott, Takeda, Wanbangde Pharmaceutical Group, Teva, Shijiazhuang No.4 Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Shanghai Sine Tianping Pharmaceutical, Shanxi Powerdone Pharmaceutical and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bromhexine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bromhexine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bromhexine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bromhexine market size, projected growth trends, production technologies, key applications, and end-use industries.

Bromhexine Segment by Company

Abbott

Takeda

Wanbangde Pharmaceutical Group

Teva

Shijiazhuang No.4 Pharmaceutical

Shanghai Xudong Haipu Pharmaceutical

Shanghai Sine Tianping Pharmaceutical

Shanxi Powerdone Pharmaceutical

Sandoz

Shanxi Powerdone Pharmaceutical

Novartis

Mylan

Jincheng Haisi Pharmaceutical

GSK

Sigma-Aldrich

Sanyo Chemical Laboratroy

Sanofi Aventis

Mayne Pharma

Ma'AnShan BBCA Pharmaceutical

LGM Pharma

Boehringer Ingelheim

Bromhexine Segment by Type

Oral

Injection

Bromhexine Segment by Application

Chronic Bronchitis

Asthma

Others

Bromhexine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhexine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bromhexine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhexine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bromhexine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bromhexine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bromhexine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bromhexine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bromhexine Industry Trends Table 2. Bromhexine Industry Drivers Table 3. Bromhexine Industry Opportunities and Challenges Table 4. Bromhexine Industry Restraints Table 5. Global Bromhexine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bromhexine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bromhexine Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Bromhexine Sales Market Share by Manufacturers Table 9. Global Bromhexine Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Bromhexine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bromhexine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bromhexine Manufacturers, Product Type & Application Table 13. Global Bromhexine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bromhexine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Bromhexine Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 19. Global Bromhexine Sales by Type (2021-2026) & (k tons) Table 20. Global Bromhexine Sales by Type (2027-2032) & (k tons) Table 21. Global Bromhexine Sales Market Share by Type (2021-2026) Table 22. Global Bromhexine Sales Market Share by Type (2027-2032) Table 23. Global Bromhexine Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 24. Global Bromhexine Revenue by Type (2021-2026) & (k tons) Table 25. Global Bromhexine Revenue by Type (2027-2032) & (k tons) Table 26. Global Bromhexine Revenue Market Share by Type (2021-2026) Table 27. Global Bromhexine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chronic Bronchitis Table 29. Major Manufacturers of Asthma Table 30. Major Manufacturers of Others Table 31. Global Bromhexine Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 32. Global Bromhexine Sales by Application (2021-2026) & (k tons) Table 33. Global Bromhexine Sales by Application (2027-2032) & (k tons) Table 34. Global Bromhexine Sales Market Share by Application (2021-2026) Table 35. Global Bromhexine Sales Market Share by Application (2027-2032) Table 36. Global Bromhexine Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 37. Global Bromhexine Revenue by Application (2021-2026) & (k tons) Table 38. Global Bromhexine Revenue by Application (2027-2032) & (k tons) Table 39. Global Bromhexine Revenue Market Share by Application (2021-2026) Table 40. Global Bromhexine Revenue Market Share by Application (2027-2032) Table 41. Global Bromhexine Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 42. Global Bromhexine Sales by Region (2021-2026) & (k tons) Table 43. Global Bromhexine Sales Market Share by Region (2021-2026) Table 44. Global Bromhexine Sales Forecasted by Region (2027-2032) & (k tons) Table 45. Global Bromhexine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 47. North America Bromhexine Sales by Country (2021-2026) & (k tons) Table 48. North America Bromhexine Sales by Country (2027-2032) & (k tons) Table 49. Europe Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 50. Europe Bromhexine Sales by Country (2021-2026) & (k tons) Table 51. Europe Bromhexine Sales by Country (2027-2032) & (k tons) Table 52. Asia Pacific Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 53. Asia Pacific Bromhexine Sales by Country (2021-2026) & (k tons) Table 54. Asia Pacific Bromhexine Sales by Country (2027-2032) & (k tons) Table 55. South America, Middle East and Africa Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. South America, Middle East and Africa Bromhexine Sales by Country (2021-2026) & (k tons) Table 57. South America, Middle East and Africa Bromhexine Sales by Country (2027-2032) & (k tons) Table 58. Global Bromhexine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bromhexine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Bromhexine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Bromhexine Revenue Market Share by Region (2021-2026) Table 62. Global Bromhexine Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Bromhexine Product Portfolio Table 67. Abbott Recent Development Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Bromhexine Product Portfolio Table 72. Takeda Recent Development Table 73. Wanbangde Pharmaceutical Group Company Information Table 74. Wanbangde Pharmaceutical Group Business Overview Table 75. Wanbangde Pharmaceutical Group Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Wanbangde Pharmaceutical Group Bromhexine Product Portfolio Table 77. Wanbangde Pharmaceutical Group Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Teva Bromhexine Product Portfolio Table 82. Teva Recent Development Table 83. Shijiazhuang No.4 Pharmaceutical Company Information Table 84. Shijiazhuang No.4 Pharmaceutical Business Overview Table 85. Shijiazhuang No.4 Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shijiazhuang No.4 Pharmaceutical Bromhexine Product Portfolio Table 87. Shijiazhuang No.4 Pharmaceutical Recent Development Table 88. Shanghai Xudong Haipu Pharmaceutical Company Information Table 89. Shanghai Xudong Haipu Pharmaceutical Business Overview Table 90. Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shanghai Xudong Haipu Pharmaceutical Bromhexine Product Portfolio Table 92. Shanghai Xudong Haipu Pharmaceutical Recent Development Table 93. Shanghai Sine Tianping Pharmaceutical Company Information Table 94. Shanghai Sine Tianping Pharmaceutical Business Overview Table 95. Shanghai Sine Tianping Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai Sine Tianping Pharmaceutical Bromhexine Product Portfolio Table 97. Shanghai Sine Tianping Pharmaceutical Recent Development Table 98. Shanxi Powerdone Pharmaceutical Company Information Table 99. Shanxi Powerdone Pharmaceutical Business Overview Table 100. Shanxi Powerdone Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio Table 102. Shanxi Powerdone Pharmaceutical Recent Development Table 103. Sandoz Company Information Table 104. Sandoz Business Overview Table 105. Sandoz Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sandoz Bromhexine Product Portfolio Table 107. Sandoz Recent Development Table 108. Shanxi Powerdone Pharmaceutical Company Information Table 109. Shanxi Powerdone Pharmaceutical Business Overview Table 110. Shanxi Powerdone Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio Table 112. Shanxi Powerdone Pharmaceutical Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Novartis Bromhexine Product Portfolio Table 117. Novartis Recent Development Table 118. Mylan Company Information Table 119. Mylan Business Overview Table 120. Mylan Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Mylan Bromhexine Product Portfolio Table 122. Mylan Recent Development Table 123. Jincheng Haisi Pharmaceutical Company Information Table 124. Jincheng Haisi Pharmaceutical Business Overview Table 125. Jincheng Haisi Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jincheng Haisi Pharmaceutical Bromhexine Product Portfolio Table 127. Jincheng Haisi Pharmaceutical Recent Development Table 128. GSK Company Information Table 129. GSK Business Overview Table 130. GSK Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. GSK Bromhexine Product Portfolio Table 132. GSK Recent Development Table 133. Sigma-Aldrich Company Information Table 134. Sigma-Aldrich Business Overview Table 135. Sigma-Aldrich Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Sigma-Aldrich Bromhexine Product Portfolio Table 137. Sigma-Aldrich Recent Development Table 138. Sanyo Chemical Laboratroy Company Information Table 139. Sanyo Chemical Laboratroy Business Overview Table 140. Sanyo Chemical Laboratroy Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Sanyo Chemical Laboratroy Bromhexine Product Portfolio Table 142. Sanyo Chemical Laboratroy Recent Development Table 143. Sanofi Aventis Company Information Table 144. Sanofi Aventis Business Overview Table 145. Sanofi Aventis Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Sanofi Aventis Bromhexine Product Portfolio Table 147. Sanofi Aventis Recent Development Table 148. Mayne Pharma Company Information Table 149. Mayne Pharma Business Overview Table 150. Mayne Pharma Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Mayne Pharma Bromhexine Product Portfolio Table 152. Mayne Pharma Recent Development Table 153. Ma'AnShan BBCA Pharmaceutical Company Information Table 154. Ma'AnShan BBCA Pharmaceutical Business Overview Table 155. Ma'AnShan BBCA Pharmaceutical Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Ma'AnShan BBCA Pharmaceutical Bromhexine Product Portfolio Table 157. Ma'AnShan BBCA Pharmaceutical Recent Development Table 158. LGM Pharma Company Information Table 159. LGM Pharma Business Overview Table 160. LGM Pharma Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. LGM Pharma Bromhexine Product Portfolio Table 162. LGM Pharma Recent Development Table 163. Boehringer Ingelheim Company Information Table 164. Boehringer Ingelheim Business Overview Table 165. Boehringer Ingelheim Bromhexine Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Boehringer Ingelheim Bromhexine Product Portfolio Table 167. Boehringer Ingelheim Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Bromhexine Distributors List Table 171. Bromhexine Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Bromhexine Product Image Figure 2. Global Bromhexine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bromhexine Market Size (2021-2032) & (US$ Million) Figure 4. Global Bromhexine Sales (2021-2032) & (k tons) Figure 5. Global Bromhexine Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Bromhexine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Bromhexine Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 11. Global Bromhexine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bromhexine Sales Market Share by Type (2021-2032) Figure 13. Global Bromhexine Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Bromhexine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bromhexine Revenue Market Share by Type (2021-2032) Figure 16. Chronic Bronchitis Image Figure 17. Asthma Image Figure 18. Others Image Figure 19. Global Bromhexine Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 20. Global Bromhexine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bromhexine Sales Market Share by Application (2021-2032) Figure 22. Global Bromhexine Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 23. Global Bromhexine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bromhexine Revenue Market Share by Application (2021-2032) Figure 25. North America Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 26. North America Bromhexine Sales Market Share by Country (2021-2032) Figure 27. U.S. Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 28. Canada Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Mexico Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Europe Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe Bromhexine Sales Market Share by Country (2021-2032) Figure 32. Germany Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 33. France Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 34. U.K. Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 35. Italy Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Netherlands Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Asia Pacific Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific Bromhexine Sales Market Share by Country (2021-2032) Figure 39. China Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Japan Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 41. South Korea Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Southeast Asia Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 43. India Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 44. Australia Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 45. South America, Middle East and Africa Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa Bromhexine Sales Market Share by Country (2021-2032) Figure 47. Brazil Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 48. South Africa Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 49. Saudi Arabia Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Turkey Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Argentina Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 52. UAE Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 53. Egypt Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Chile Bromhexine Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Global Bromhexine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Bromhexine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Bromhexine Revenue (2021-2032) & (US$ Million) Figure 58. North America Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Bromhexine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bromhexine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Bromhexine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bromhexine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bromhexine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Chronic Bronchitis
  • Asthma
  • Others
Companies covered
  • Abbott
  • Takeda
  • Wanbangde Pharmaceutical Group
  • Teva
  • Shijiazhuang No.4 Pharmaceutical
  • Shanghai Xudong Haipu Pharmaceutical
  • Shanghai Sine Tianping Pharmaceutical
  • Shanxi Powerdone Pharmaceutical
  • Sandoz
  • Shanxi Powerdone Pharmaceutical
  • Novartis
  • Mylan
  • Jincheng Haisi Pharmaceutical
  • GSK
  • Sigma-Aldrich
  • Sanyo Chemical Laboratroy
  • Sanofi Aventis
  • Mayne Pharma
  • Ma'AnShan BBCA Pharmaceutical
  • LGM Pharma
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bromhexine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bromhexine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bromhexine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bromhexine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bromhexine Market Dynamics
  1. 2.1 Bromhexine Industry Trends
  2. 2.2 Bromhexine Industry Drivers
  3. 2.3 Bromhexine Industry Opportunities and Challenges
  4. 2.4 Bromhexine Industry Restraints
3 Bromhexine Market by Manufacturers
  1. 3.1 Global Bromhexine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bromhexine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bromhexine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bromhexine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bromhexine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bromhexine Manufacturers, Product Type & Application
  7. 3.7 Global Bromhexine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bromhexine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bromhexine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bromhexine Tier 1, Tier 2, and Tier 3
4 Bromhexine Market by Type
  1. 4.1 Bromhexine Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Bromhexine Sales by Type
  5. 4.2.1 Global Bromhexine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bromhexine Sales by Type (2021-2032)
  7. 4.2.3 Global Bromhexine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bromhexine Revenue by Type
  9. 4.3.1 Global Bromhexine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bromhexine Revenue by Type (2021-2032)
  11. 4.3.3 Global Bromhexine Revenue Market Share by Type (2021-2032)
5 Bromhexine Market by Application
  1. 5.1 Bromhexine Application Introduction
  2. 5.1.1 Chronic Bronchitis
  3. 5.1.2 Asthma
  4. 5.1.3 Others
  5. 5.2 Global Bromhexine Sales by Application
  6. 5.2.1 Global Bromhexine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bromhexine Sales by Application (2021-2032)
  8. 5.2.3 Global Bromhexine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Bromhexine Revenue by Application
  10. 5.3.1 Global Bromhexine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bromhexine Revenue by Application (2021-2032)
  12. 5.3.3 Global Bromhexine Revenue Market Share by Application (2021-2032)
6 Global Bromhexine Sales by Region
  1. 6.1 Global Bromhexine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bromhexine Sales by Region (2021-2032)
  3. 6.2.1 Global Bromhexine Sales by Region (2021-2026)
  4. 6.2.2 Global Bromhexine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bromhexine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bromhexine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bromhexine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bromhexine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bromhexine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bromhexine Revenue by Region
  1. 7.1 Global Bromhexine Revenue by Region
  2. 7.1.1 Global Bromhexine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bromhexine Revenue by Region (2021-2026)
  4. 7.1.3 Global Bromhexine Revenue by Region (2027-2032)
  5. 7.1.4 Global Bromhexine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bromhexine Revenue (2021-2032)
  8. 7.2.2 North America Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bromhexine Revenue (2021-2032)
  11. 7.3.2 Europe Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bromhexine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bromhexine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bromhexine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Bromhexine Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Bromhexine Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Wanbangde Pharmaceutical Group
  14. 8.3.1 Wanbangde Pharmaceutical Group Company Information
  15. 8.3.2 Wanbangde Pharmaceutical Group Business Overview
  16. 8.3.3 Wanbangde Pharmaceutical Group Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wanbangde Pharmaceutical Group Bromhexine Product Portfolio
  18. 8.3.5 Wanbangde Pharmaceutical Group Recent Developments
  19. 8.4 Teva
  20. 8.4.1 Teva Company Information
  21. 8.4.2 Teva Business Overview
  22. 8.4.3 Teva Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Bromhexine Product Portfolio
  24. 8.4.5 Teva Recent Developments
  25. 8.5 Shijiazhuang No.4 Pharmaceutical
  26. 8.5.1 Shijiazhuang No.4 Pharmaceutical Company Information
  27. 8.5.2 Shijiazhuang No.4 Pharmaceutical Business Overview
  28. 8.5.3 Shijiazhuang No.4 Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shijiazhuang No.4 Pharmaceutical Bromhexine Product Portfolio
  30. 8.5.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
  31. 8.6 Shanghai Xudong Haipu Pharmaceutical
  32. 8.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
  33. 8.6.2 Shanghai Xudong Haipu Pharmaceutical Business Overview
  34. 8.6.3 Shanghai Xudong Haipu Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xudong Haipu Pharmaceutical Bromhexine Product Portfolio
  36. 8.6.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments
  37. 8.7 Shanghai Sine Tianping Pharmaceutical
  38. 8.7.1 Shanghai Sine Tianping Pharmaceutical Company Information
  39. 8.7.2 Shanghai Sine Tianping Pharmaceutical Business Overview
  40. 8.7.3 Shanghai Sine Tianping Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Sine Tianping Pharmaceutical Bromhexine Product Portfolio
  42. 8.7.5 Shanghai Sine Tianping Pharmaceutical Recent Developments
  43. 8.8 Shanxi Powerdone Pharmaceutical
  44. 8.8.1 Shanxi Powerdone Pharmaceutical Company Information
  45. 8.8.2 Shanxi Powerdone Pharmaceutical Business Overview
  46. 8.8.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
  48. 8.8.5 Shanxi Powerdone Pharmaceutical Recent Developments
  49. 8.9 Sandoz
  50. 8.9.1 Sandoz Company Information
  51. 8.9.2 Sandoz Business Overview
  52. 8.9.3 Sandoz Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sandoz Bromhexine Product Portfolio
  54. 8.9.5 Sandoz Recent Developments
  55. 8.10 Shanxi Powerdone Pharmaceutical
  56. 8.10.1 Shanxi Powerdone Pharmaceutical Company Information
  57. 8.10.2 Shanxi Powerdone Pharmaceutical Business Overview
  58. 8.10.3 Shanxi Powerdone Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanxi Powerdone Pharmaceutical Bromhexine Product Portfolio
  60. 8.10.5 Shanxi Powerdone Pharmaceutical Recent Developments
  61. 8.11 Novartis
  62. 8.11.1 Novartis Company Information
  63. 8.11.2 Novartis Business Overview
  64. 8.11.3 Novartis Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novartis Bromhexine Product Portfolio
  66. 8.11.5 Novartis Recent Developments
  67. 8.12 Mylan
  68. 8.12.1 Mylan Company Information
  69. 8.12.2 Mylan Business Overview
  70. 8.12.3 Mylan Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mylan Bromhexine Product Portfolio
  72. 8.12.5 Mylan Recent Developments
  73. 8.13 Jincheng Haisi Pharmaceutical
  74. 8.13.1 Jincheng Haisi Pharmaceutical Company Information
  75. 8.13.2 Jincheng Haisi Pharmaceutical Business Overview
  76. 8.13.3 Jincheng Haisi Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jincheng Haisi Pharmaceutical Bromhexine Product Portfolio
  78. 8.13.5 Jincheng Haisi Pharmaceutical Recent Developments
  79. 8.14 GSK
  80. 8.14.1 GSK Company Information
  81. 8.14.2 GSK Business Overview
  82. 8.14.3 GSK Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GSK Bromhexine Product Portfolio
  84. 8.14.5 GSK Recent Developments
  85. 8.15 Sigma-Aldrich
  86. 8.15.1 Sigma-Aldrich Company Information
  87. 8.15.2 Sigma-Aldrich Business Overview
  88. 8.15.3 Sigma-Aldrich Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sigma-Aldrich Bromhexine Product Portfolio
  90. 8.15.5 Sigma-Aldrich Recent Developments
  91. 8.16 Sanyo Chemical Laboratroy
  92. 8.16.1 Sanyo Chemical Laboratroy Company Information
  93. 8.16.2 Sanyo Chemical Laboratroy Business Overview
  94. 8.16.3 Sanyo Chemical Laboratroy Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sanyo Chemical Laboratroy Bromhexine Product Portfolio
  96. 8.16.5 Sanyo Chemical Laboratroy Recent Developments
  97. 8.17 Sanofi Aventis
  98. 8.17.1 Sanofi Aventis Company Information
  99. 8.17.2 Sanofi Aventis Business Overview
  100. 8.17.3 Sanofi Aventis Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sanofi Aventis Bromhexine Product Portfolio
  102. 8.17.5 Sanofi Aventis Recent Developments
  103. 8.18 Mayne Pharma
  104. 8.18.1 Mayne Pharma Company Information
  105. 8.18.2 Mayne Pharma Business Overview
  106. 8.18.3 Mayne Pharma Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Mayne Pharma Bromhexine Product Portfolio
  108. 8.18.5 Mayne Pharma Recent Developments
  109. 8.19 Ma'AnShan BBCA Pharmaceutical
  110. 8.19.1 Ma'AnShan BBCA Pharmaceutical Company Information
  111. 8.19.2 Ma'AnShan BBCA Pharmaceutical Business Overview
  112. 8.19.3 Ma'AnShan BBCA Pharmaceutical Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Ma'AnShan BBCA Pharmaceutical Bromhexine Product Portfolio
  114. 8.19.5 Ma'AnShan BBCA Pharmaceutical Recent Developments
  115. 8.20 LGM Pharma
  116. 8.20.1 LGM Pharma Company Information
  117. 8.20.2 LGM Pharma Business Overview
  118. 8.20.3 LGM Pharma Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 LGM Pharma Bromhexine Product Portfolio
  120. 8.20.5 LGM Pharma Recent Developments
  121. 8.21 Boehringer Ingelheim
  122. 8.21.1 Boehringer Ingelheim Company Information
  123. 8.21.2 Boehringer Ingelheim Business Overview
  124. 8.21.3 Boehringer Ingelheim Bromhexine Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Boehringer Ingelheim Bromhexine Product Portfolio
  126. 8.21.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bromhexine Value Chain Analysis
  2. 9.1.1 Bromhexine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bromhexine Production Mode & Process
  6. 9.2 Bromhexine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bromhexine Distributors
  9. 9.2.3 Bromhexine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst